QQ客服 官方微博 反馈留言

浏览/检索结果: 共3条，第1-3条 帮助 已选(0)清除 条数/页：5101520253035404550556065707580859095100   排序方式：请选择作者升序作者降序题名升序题名降序发表日期升序发表日期降序提交时间升序提交时间降序 A Multicenter, Double-Blind, Randomized, Noninferiority Comparison of 14 Days' Treatment with Oral Olopatadine 10 mg or Cetirizine 10 mg in Chinese Adults with Cutaneous Pruritus 期刊论文 PHARMACOLOGY, 2013, 卷号: 91, 期号: 1-2 作者:  Wang, Tao;  Liu, Yuehua;  Yin, Jia;  Lian, Shi;  Li, Ming 收藏  |  浏览/下载：6/0  |  提交时间：2019/12/19 Pruritus  Cutaneous  H1 receptor blocking agent.  Olopatadine hydrochloride  Cetirizine   A Multicenter, Double-Blind, Randomized, Noninferiority Comparison of 14 Days' Treatment with Oral Olopatadine 10 mg or Cetirizine 10 mg in Chinese Adults with Cutaneous Pruritus 期刊论文 2013, 卷号: 91, 期号: 1-2, 页码: 117-122 作者:  Wang, Tao;  Liu, Yuehua;  Yin, Jia;  Lian, Shi;  Li, Ming 收藏  |  浏览/下载：3/0  |  提交时间：2020/01/13 Pruritus  Cutaneous  H1 receptor blocking agent.  Olopatadine hydrochloride  Cetirizine   Loteprednol Etabonate Ophthalmic Suspension, 0.2% Is As Safe as Olopatadine Hydrochloride Ophthalmic Solution, 0.1% With Superior Relief of Signs and Symptoms In The Treatment of Seasonal Allergic Conjunctivitis 会议论文 作者:  Elion-Mboussa, A.;  Gong, L.;  Roy, L.;  Zhu, B.;  DeCory, H. 收藏  |  浏览/下载：2/0  |  提交时间：2019/12/19